PACS PACS Group, Inc.
Services-Skilled Nursing Care Facilities · NYSE · SEC CIK 2001184 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.0%
TTM net income YoY64.2%
TTM EPS YoY67.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin23.8%
Operating margin7.4%
Net margin4.9%
FCF margin—
EBITDA margin—
Returns
ROE26.6%
ROA4.8%
ROIC (approx.)27.6%
Asset turnover0.99x
Leverage & solvency
Liabilities / assets79.4%
Debt / equity0.22x
Current ratio0.80x
Interest coverage16.21x
Cash quality & payout
Operating cash flow / net income2.09x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $5.29B | $4.09B | $3.11B | $2.42B |
| Cost of revenue | $4.13B | $3.30B | $2.45B | $1.86B |
| Gross profit | $1.16B | $792.64M | $663.78M | $560.68M |
| SG&A expense | $415.07M | $343.81M | $213.66M | $149.01M |
| Operating income | $309.60M | $123.07M | $207.77M | $229.36M |
| Interest expense | $28.36M | $44.34M | $49.92M | $25.54M |
| Pretax income | $284.45M | $101.55M | $157.32M | $207.04M |
| Income tax | $92.99M | $46.21M | $44.44M | $56.55M |
| Net income | $191.54M | $55.76M | $112.87M | $150.50M |
| EPS (basic) | 1.23 | 0.38 | 0.88 | 1.17 |
| EPS (diluted) | 1.22 | 0.38 | 0.88 | 1.17 |
| Dividends declared per share | — | 0.22 | 0.62 | 0.47 |
| Weighted avg. shares (diluted) | 156.70M | 148.57M | 128.72M | 128.72M |
| Balance sheet | ||||
| Cash & equivalents | $197.02M | $160.84M | $73.42M | $98.21M |
| Receivables | $628.13M | $641.77M | $547.81M | — |
| Current assets | $1.07B | $938.26M | $722.15M | — |
| PP&E, net | $1.20B | $990.58M | $577.53M | — |
| Goodwill | $61.79M | $60.79M | $59.02M | $55.22M |
| Total assets | $5.58B | $5.24B | $3.51B | — |
| Current liabilities | $1.00B | $978.43M | $456.93M | — |
| Short-term debt | $4.46M | $14.85M | $16.82M | — |
| Long-term debt | $244.80M | $250.98M | $195.71M | — |
| Total debt | $249.27M | $265.84M | $212.53M | — |
| Total liabilities | $4.63B | $4.53B | $3.41B | — |
| Shareholders' equity | $946.77M | $709.55M | $96.13M | $68.65M |
| Net debt | $52.25M | $104.99M | $139.11M | — |
| Shares outstanding | 156.62M | 155.18M | 128.72M | — |
| Cash flow statement | ||||
| Operating cash flow | $404.22M | $367.34M | $63.70M | $92.61M |
| Investing cash flow | -$264.02M | -$442.68M | -$172.79M | -$75.32M |
| Financing cash flow | -$68.99M | $117.48M | $129.59M | $12.35M |
| Stock-based compensation | $54.07M | $115.54M | $0 | $0 |
| Dividends paid | $0 | $33.72M | $80.39M | $60.28M |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.